Vote now in the 2021 Best of San Antonio Readers Poll.

Friday, May 3, 2019

San Antonio Research Facility to Collaborate on Developing HIV Vaccine

Posted By on Fri, May 3, 2019 at 12:49 PM

Dr. Ruth Ruprecht, director of the Texas Biomed AIDS Research Program - COURTESY
  • Courtesy
  • Dr. Ruth Ruprecht, director of the Texas Biomed AIDS Research Program
This article was originally published by our sister publication Out In SA.

The National Institutes of Health has awarded $8.67 million to Texas Biomedical Research Institute in San Antonio and Mymetics Corporation of Switzerland to collaborate on the development of an HIV vaccine.

Mymetics, a Swiss-based biotechnology company which has a research lab in the Netherlands, focuses on the development of next-generation preventative vaccines for infectious and life disabling diseases. Texas Biomedical Research Institute is one of the world’s leading independent biomedical research institutions.

Also participating in the study are researchers from the University of Louisiana at Lafayette and the University of Virginia.

The goal of the joint project is to produce a vaccine that is easy to administer and does not need to be refrigerated, both important considerations for clinics in the developing world where AIDS is most prevalent.

Mymetics previously started work on a vaccine in powdered form which can be administered through the nose or orally. Working with Texas Biomedical, Mymetics will seek to prepare the vaccine for clinical trials within five years.

Dr. Ruth Ruprecht, director of the Texas Biomed AIDS Research Program, told KENS-TV that tests of the vaccine first will be conducted on non-human primates. “We need to have an animal model that replicates the biology of HIV transmission and progression in people,” she said.

“We are extremely grateful for the trust and support from the NIH for our project, it will enable the continued progress of our cold chain, independent virosome-based HIV vaccine candidate,” Ronald Kempers, CEO of Mymetics, said in a press announcement. “We will be able to prepare it for clinical trials in collaboration with world leading HIV scientists . . . and our longstanding partner Texas Biomed.”

Stay on top of San Antonio news and views. Sign up for our Weekly Headlines Newsletter.

Tags: , , , , , ,

Support Local Journalism.
Join the San Antonio Current Press Club

Local journalism is information. Information is power. And we believe everyone deserves access to accurate independent coverage of their community and state. Our readers helped us continue this coverage in 2020, and we are so grateful for the support.

Help us keep this coverage going in 2021. Whether it's a one-time acknowledgement of this article or an ongoing membership pledge, your support goes to local-based reporting from our small but mighty team.

Join the San Antonio Press Club for as little as $5 a month.

Read the Digital Print Issue

June 2, 2021

View more issues


Join SA Current Newsletters

Sign Up Now

Subscribe now to get the latest news delivered right to your inbox.


© 2021 San Antonio Current

Website powered by Foundation